The peptide neuromedin U (NMU) is elevated in NYHA II and III heart failure
ConclusionsNMU is elevated in serum from stage II and III heart failure patients, supporting data from our pre-heart failure animal model; however, further study is needed to determine whether NMU is a reliable biomarker for pre-heart failure.
Source: ESC Heart Failure - Category: Cardiology Authors: Vincent Healy,
Therese Ruane O'Hora,
Farouk Markos Tags: Original Article Source Type: research
More News: Brain | Cardiology | Heart | Heart Failure | Neurology | Students | Study | Universities & Medical Training